Add BrightSurf on Google Email

Research redefines pneumonia and sepsis care — and exposes urgent gaps in Ireland’s critical care capacity

Two landmark international studies published in The Lancet and Nature Medicine expose the need for faster recognition, better diagnostics, and personalized treatment pathways to combat pneumonia and sepsis. Irish ICUs face a shortage of beds, with implications for delayed care and increased mortality.

SourceTrinity College Dublin·JournalNature Medicine·TypeObservational study·DateNov 3, 2025

N6-methyladenosine methylation emerges as a key target for treating acute lung injury

Acute lung injury is characterized by diffuse inflammation and intractable hypoxemia, with N6-methyladenosine methylation playing a crucial role in its pathogenesis. The review synthesizes findings from multiple studies, highlighting the dynamic nature of m6A methylation and its associated proteins.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeLiterature review·DateOct 30, 2025

Practice pattern of aerosol drug therapy in acute respiratory distress syndrome patients: An aero-in-ICU study

The study highlights the frequent use of aerosol therapy in critically ill patients with acute respiratory distress syndrome (ARDS), with bronchodilators being the most commonly prescribed drugs. However, the lack of sound scientific evidence and randomized controlled trials suggests that standardized protocols are needed to align clin...

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeObservational study·DateOct 29, 2025

Deciding whether a breathing tube is best for a child

The American Thoracic Society's new Clinical Practice Guideline provides evidence-based recommendations for tracheostomy care in children. The guideline emphasizes the importance of applying ethical principles and involving caregivers in decision-making, with a focus on ensuring high-quality, family-centered care.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateOct 22, 2025

US funding cuts could result in nearly 9 million child tuberculosis cases, 1.5 million child deaths

A new study projects that US funding cuts will result in a catastrophic effect on pediatric TB, with children in Sub-Saharan Africa and Southeast Asia experiencing a significant spike in preventable cases and deaths over the next decade. The loss of US bilateral health aid is projected to result in an additional 2.5 million pediatric T...

SourceBoston University School of Public Health·JournalThe Lancet Child & Adolescent Health·TypeComputational simulation/modeling·DateOct 20, 2025

NSAID-exacerbated respiratory disease is associated with changes in lipid metabolism

Researchers discovered reduced concentrations of key lipids in patients with NSAID-exacerbated respiratory disease (N-ERD), whereas healthy controls showed increased levels with low-dose aspirin. Elevated lipid mediators linked to inflammation were also observed, suggesting potential new diagnostic and treatment options.

SourceUniversity of Eastern Finland·JournalClinical & Experimental Allergy·DateOct 13, 2025

UVA Health developing way to ID people at risk of dangerous lung scarring even before symptoms appear

Researchers aim to determine if biomarkers can identify adults at risk of developing interstitial lung disease (ILD), a chronic condition that causes inflammation and scarring in the lung tissue. The approach could lead to the development of new, better treatments with more tolerable side effects.

SourceUniversity of Virginia Health System·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateOct 10, 2025

USC physician-scientists Denis Evseenko and Toby Maher win $3.2 million grant from the National Institute on Aging to develop regenerative drug for idiopathic pulmonary fibrosis

Denis Evseenko and Toby Maher are developing a regenerative drug to block cells that promote fibrosis in the lungs, aiming to slow or reverse IPF damage. The team plans to test the safety and therapeutic potential of their drug-like molecules in animals and human cells.

Hypnosis can make ventilation masks more acceptable to patients with breathing problems

A pilot study found that hypnosis significantly improved patients' tolerance of masks, allowing them to breathe more comfortably. The study showed a substantial improvement in non-invasive ventilation (NIV) tolerance, reduced agitation, and lower requirements for sedation and anti-anxiety medication.

SourceEuropean Society for Emergency Medicine (EUSEM)·TypeRandomized controlled/clinical trial·DateSep 28, 2025

Specialised singing programmes can improve the symptoms and quality of life of people with lung disease

A gold-standard randomised-controlled trial found that specialised singing programmes can improve the symptoms and quality of life of people with lung disease, particularly those with chronic breathlessness. The SINFONIA study showed a significant improvement in quality of life for patients with COPD and ILD.

SourceEuropean Respiratory Society·TypeRandomized controlled/clinical trial·DateSep 28, 2025

American College of Chest Physicians leads landmark effort to improve access to lifesaving noninvasive ventilation for patients with COPD

The American College of Chest Physicians has achieved a critical milestone in its advocacy efforts, leading to changes in federal coverage guidelines for noninvasive ventilation devices used in the home. These revised guidelines reflect major recommendations submitted by CHEST and aim to enhance patient care.

What stiffening lung tissue reveals about the earliest stages of fibrosis

Penn Engineering researchers used a technique called photochemical cross-linking to stiffen lung tissue, revealing changes in cell behavior that may drive fibrosis. The team observed transitional cells caught in an identity crisis, unable to perform either role well, which contributed to disease progression.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Materials·TypeExperimental study·DateSep 5, 2025

New guideline offers menu of options to help people quit smoking tobacco

A new guideline from the Canadian Task Force on Preventive Health Care provides a menu of effective options to help people quit smoking, including behavioural and medication options. The guideline aims to address the challenges of nicotine addiction and offers personalized choices for quitting tobacco.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeSystematic review·DateAug 25, 2025

Ancient practice of blowing through a conch shell could help to treat dangerous snoring condition

A small randomized controlled trial found that blowing through a conch shell for six months reduced symptoms of obstructive sleep apnea, including daytime sleepiness and breathing interruptions. The study suggests that conch blowing may be a simple, low-cost alternative to traditional treatments like CPAP.

SourceEuropean Respiratory Society·JournalERJ Open Research·TypeRandomized controlled/clinical trial·DateAug 10, 2025

Going in for a close look at lung infections

A new study sampled different lung regions in cystic fibrosis patients before and after treatment with modulators, revealing that infections persisted throughout the lungs and drove inflammation. The findings suggest damage may not be the main cause of infection persistence, raising concerns about ongoing lung function deterioration.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalCell Host & Microbe·TypeExperimental study·DateAug 5, 2025